Singapore markets closed

Capricor Therapeutics, Inc. (CAPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.29-0.01 (-0.16%)
At close: 04:00PM EDT
6.44 +0.15 (+2.38%)
Pre-market: 08:08AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 200.09M
Enterprise value 162.20M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)6.57
Price/book (mrq)10.85
Enterprise value/revenue 5.99
Enterprise value/EBITDA -3.14

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 334.12%
S&P500 52-week change 329.31%
52-week high 38.22
52-week low 32.68
50-day moving average 35.95
200-day moving average 34.80

Share statistics

Avg vol (3-month) 3366.57k
Avg vol (10-day) 3364.04k
Shares outstanding 531.81M
Implied shares outstanding 631.86M
Float 826M
% held by insiders 18.26%
% held by institutions 123.93%
Shares short (30 Apr 2024) 44.14M
Short ratio (30 Apr 2024) 410.91
Short % of float (30 Apr 2024) 415.85%
Short % of shares outstanding (30 Apr 2024) 413.15%
Shares short (prior month 28 Mar 2024) 43.5M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Jun 2019
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 305 Jun 2019

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -89.72%
Operating margin (ttm)-209.21%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)27.1M
Revenue per share (ttm)0.96
Quarterly revenue growth (yoy)64.30%
Gross profit (ttm)N/A
EBITDA -25.05M
Net income avi to common (ttm)-24.31M
Diluted EPS (ttm)-0.83
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)N/A
Total cash per share (mrq)N/A
Total debt (mrq)N/A
Total debt/equity (mrq)9.89%
Current ratio (mrq)N/A
Book value per share (mrq)0.73

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A